Kempen & Co acted as Co-Manager in Pharvaris’ Initial Public Offering on the Nasdaq Global Select Market, successfully raising USD 165 million
In the last twelve months, Kempen & Co has successfully completed a large number of transactions in its Life Sciences & Healthcare franchise. Recent transactions include: